BRK-B vs CME
By Alex · Tickerpine
Berkshire Hathaway Inc. vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | BRK-B | CME |
|---|---|---|
| Price | $592.94 | $317.97 |
| Market cap | $1.26T | $113.81B |
| P/E ratio | 16.6 | 26.1 |
| ROE | 10.57% | 16.13% |
| Profit margin | 19.50% | 63.48% |
| Revenue growth | 11.20% | 13.00% |
| Dividend yield | 0.00% | 1.64% |
| Beta | 0.57 | 0.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
BRK-B vs CME in plain English
- BRK-B is the bigger company — about 11.1× the market cap of CME.
- BRK-B is cheaper on earnings (P/E 16.6 vs 26.1).
- CME earns a higher return on equity (16% vs 11%).
- CME is growing revenue faster (13% vs 11%).
- CME pays a dividend (1.64%) while the other effectively doesn't.
How would $1,000 have done in each?
BRK-B return calculator
See what $1,000 in Berkshire Hathaway Inc. would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.